SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19.
Glück V, Grobecker S, Tydykov L, Salzberger B, Glück T, Weidlich T, Bertok M, Gottwald C, Wenzel JJ, Gessner A, Schmidt B, Peterhoff D.
Glück V, et al. Among authors: salzberger b.
Infection. 2021 Aug;49(4):739-746. doi: 10.1007/s15010-021-01598-6. Epub 2021 Mar 10.
Infection. 2021.
PMID: 33689159
Free PMC article.